Weizhong Chen, Jiexiu Zhang, Huagui Wei, Jie Su, Jie Lin, Xueyan Liang, Jiangtao Chen, Rong Zhou, Lin Li, Zefang Lu, Guangyu Sun
{"title":"Rapid and sensitive detection of methicillin-resistant <i>Staphylococcus aureus</i> through the RPA-<i>Pf</i>Ago system.","authors":"Weizhong Chen, Jiexiu Zhang, Huagui Wei, Jie Su, Jie Lin, Xueyan Liang, Jiangtao Chen, Rong Zhou, Lin Li, Zefang Lu, Guangyu Sun","doi":"10.3389/fmicb.2024.1422574","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Both the incidence and mortality rates associated with methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) have progressively increased worldwide. A nucleic acid testing system was developed in response, enabling swift and precise detection of <i>Staphylococcus aureus</i> (<i>S. aureus</i>) and its MRSA infection status. This facilitates improved prevention and control of MRSA infections.</p><p><strong>Methods: </strong>In this work, we introduce a novel assay platform developed by integrating <i>Pyrococcus furiosus</i> Argonaute (<i>Pf</i>Ago) with recombinase polymerase amplification (RPA), which was designed for the simultaneous detection of the <i>nuc</i> and <i>mecA</i> genes in MRSA.</p><p><strong>Results: </strong>This innovative approach enables visual MRSA detection within 55 mins, boasting a detection limit of 10<sup>2</sup> copies/μL. Characterized by its high specificity, the platform accurately identifies MRSA infections without cross-reactivity to other clinical pathogens, highlighting its unique capability for <i>S. aureus</i> infection diagnostics amidst bacterial diversity. Validation of this method was performed on 40 clinical isolates, demonstrating a 95.0% accuracy rate in comparison to the established Vitek2-COMPACT system.</p><p><strong>Discussion: </strong>The RPA-<i>Pf</i>Ago platform has emerged as a superior diagnostic tool, offering enhanced sensitivity, specificity, and identification efficacy for MRSA detection. Our findings underscore the potential of this platform to significantly improve the diagnosis and management of MRSA infection.</p>","PeriodicalId":12466,"journal":{"name":"Frontiers in Microbiology","volume":null,"pages":null},"PeriodicalIF":4.0000,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11371615/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Microbiology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.3389/fmicb.2024.1422574","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Both the incidence and mortality rates associated with methicillin-resistant Staphylococcus aureus (MRSA) have progressively increased worldwide. A nucleic acid testing system was developed in response, enabling swift and precise detection of Staphylococcus aureus (S. aureus) and its MRSA infection status. This facilitates improved prevention and control of MRSA infections.
Methods: In this work, we introduce a novel assay platform developed by integrating Pyrococcus furiosus Argonaute (PfAgo) with recombinase polymerase amplification (RPA), which was designed for the simultaneous detection of the nuc and mecA genes in MRSA.
Results: This innovative approach enables visual MRSA detection within 55 mins, boasting a detection limit of 102 copies/μL. Characterized by its high specificity, the platform accurately identifies MRSA infections without cross-reactivity to other clinical pathogens, highlighting its unique capability for S. aureus infection diagnostics amidst bacterial diversity. Validation of this method was performed on 40 clinical isolates, demonstrating a 95.0% accuracy rate in comparison to the established Vitek2-COMPACT system.
Discussion: The RPA-PfAgo platform has emerged as a superior diagnostic tool, offering enhanced sensitivity, specificity, and identification efficacy for MRSA detection. Our findings underscore the potential of this platform to significantly improve the diagnosis and management of MRSA infection.
期刊介绍:
Frontiers in Microbiology is a leading journal in its field, publishing rigorously peer-reviewed research across the entire spectrum of microbiology. Field Chief Editor Martin G. Klotz at Washington State University is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.